1. Concord Biotech
stock logo

34% Hold

Concord Biotech Share Price

CONCORDBIO

₹1,694.70-₹26.25 (-1.53%) TodayLast updated on 25 Jul, 2024 | 15:50 IST
₹1,690.05₹1,728.55
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹17,995 Crs

Open

₹1,720.95

Close

₹1,720.95

Circuit range

₹2,065.10 - ₹1,376.80

Day range

₹1,690.05 - ₹1,728.55

Year range

₹900.05 - ₹1,799.00

Volume

50,917

Avg. traded

₹1,702.34

Revenue (12m)

₹1,017 Crs

Concord BiotechConcord Biotech Limited is an India-based research and development driven biopharma company. The Company is engaged in the research and development, manufacturing, marketing, and selling of pharmaceutical products. The Company manufactures active pharmaceutical ingredients (API) through fermentation and semi-synthetic processes and finished formulations. It manufactures fermentation and semi-synthetic based products in the therapeutic segments, such as immunosuppressants, anti-bacterial, oncology, anti-fungal and others. Its API products include Mycophenolate Mofetil, Mycophenolate Sodium, Cyclosporine, Vancomycin Hydrochloride, Micafungin Sodium, Mupirocin, Romidepsin, Dactinomycin, and Pravastatin Sodium, among others. It also has a pipeline of API products under development. Its API products under development include Polymyxin B, Fidaxomicin, Doxorubicin, and others. The Company provides products in the critical care, immunology, nephrology, and transplant medicine segments.

Concord Biotech Key indicators

arrow

52 week high

₹1,799.00

52 week low

₹900.05

P/E ratio

58.43

P/B ratio

11.63

ROE

21.63%

ROCE

28.89%

Dividend yield

0.52%

Debt/Equity ratio

EPS

29.13

Learn more

Investment checklist: (2/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Hold

arrow

Buy

33%

Hold

34%

Sell

33%

This analysis is based on the reviews of 3 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

45.82%

Net profit margin

29.97%

ROE

21.63%

ROA

18.96%

ROCE

28.89%

Learn more

Concord Biotech Shareholder returns

arrow

1 day

+0.05%

1 week

+1.12%

1 month

+13.07%

3 months

+5.61%

1 year

+82.54%

3 years

+82.54%

5 years

+82.54%

Concord Biotech Share Price history

arrow
DayOpenCloseDay’s change
Wed, Jul 24 2024
₹1,730.00
₹1,720.95
+0.05%
Tue, Jul 23 2024
₹1,661.00
₹1,720.05
+3.43%
Mon, Jul 22 2024
₹1,636.95
₹1,663.00
-0.57%
Fri, Jul 19 2024
₹1,706.20
₹1,672.55
-1.39%
Thu, Jul 18 2024
₹1,701.85
₹1,696.20
-0.33%
Tue, Jul 16 2024
₹1,738.95
₹1,701.85
-0.67%
Mon, Jul 15 2024
₹1,700.00
₹1,713.25
+1.38%
Fri, Jul 12 2024
₹1,676.00
₹1,689.90
0.00%

Shareholding info

arrow

Promoters (44.08%)

Mutual Funds (5.26%)

Retail and other (38.46%)

Foreign institutions-FII (7.11%)

Other domestic institutions (5.09%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹8.75/share

    Ex date 21 Jun 2024

    expand tab

Learn more

More

Frequently asked questions